BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15890654)

  • 1. A novel anti-platelet monoclonal antibody (3C7) specific for the complex of integrin alpha IIb beta3 inhibits platelet aggregation and adhesion.
    Chen P; Sun CX; Liu JN
    J Biol Chem; 2005 Jul; 280(27):25403-8. PubMed ID: 15890654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin).
    Tokuhira M; Handa M; Kamata T; Oda A; Katayama M; Tomiyama Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
    Thromb Haemost; 1996 Dec; 76(6):1038-46. PubMed ID: 8972029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6.
    Nurden P; Humbert M; Piotrowicz RS; Bihour C; Poujol C; Nurden AT; Kunicki TJ
    Blood; 1996 Aug; 88(3):887-99. PubMed ID: 8704246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of monoclonal antibodies to murine platelet glycoprotein IIb/IIIa (alphaIIbbeta3) and other proteins from hamster-mouse interspecies hybridomas.
    Lengweiler S; Smyth SS; Jirouskova M; Scudder LE; Park H; Moran T; Coller BS
    Biochem Biophys Res Commun; 1999 Aug; 262(1):167-73. PubMed ID: 10448087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes and biological activities of two monoclonal antibodies to platelet integrin alpha IIb beta 3.
    Yano S; Suzuki K; Katoh M; Sugita Y; Kaku S; Kawamura K; Masuho Y
    J Biochem; 1994 Oct; 116(4):778-86. PubMed ID: 7533762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa.
    Mazurov AV; Khaspekova SG; Byzova TV; Tikhomirov OYu ; Berndt MC; Steiner B; Kouns WC
    FEBS Lett; 1996 Aug; 391(1-2):84-8. PubMed ID: 8706936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation studies with anti-CD41/61 monoclonal antibodies.
    Mateo A; Perez de la Lastra JM; Garrido JJ; Llanes D
    Vet Immunol Immunopathol; 1996 Aug; 52(4):357-62. PubMed ID: 8896225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).
    Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V
    Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
    Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
    Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation.
    Kamae T; Shiraga M; Kashiwagi H; Kato H; Tadokoro S; Kurata Y; Tomiyama Y; Kanakura Y
    J Thromb Haemost; 2006 Jun; 4(6):1379-87. PubMed ID: 16706985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible exposure of human platelet fibrinogen receptors by antiplatelet tetraspanin monoclonal antibodies via induction of a conformational change in membrane glycoprotein IIb/IIIa complex.
    Wu H; Peng L; Li J; Wu W; Hou Q; Liu H; Wang M
    Thromb Res; 1999 Sep; 95(5):245-53. PubMed ID: 10515289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
    Shattil SJ; Hoxie JA; Cunningham M; Brass LF
    J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tripeptide mimetic of von Willebrand factor residues 981-983 enhances platelet adhesion to fibrinogen by signaling through integrin alpha(IIb)beta3.
    Litjens PE; Van Willigen G; Weeterings C; Ijsseldijk MJ; Van Lier M; Koivunen E; Gahmberg CG; Akkerman JW
    J Thromb Haemost; 2005 Jun; 3(6):1274-83. PubMed ID: 15946218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb).
    Basani RB; D'Andrea G; Mitra N; Vilaire G; Richberg M; Kowalska MA; Bennett JS; Poncz M
    J Biol Chem; 2001 Apr; 276(17):13975-81. PubMed ID: 11278919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
    Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence 274-368 in the beta 3-subunit of the integrin alpha IIb beta 3 provides a ligand recognition and binding domain for the gamma-chain of fibrinogen that is independent of platelet activation.
    Alemany M; Concord E; Garin J; Vinçon M; Giles A; Marguerie G; Gulino D
    Blood; 1996 Jan; 87(2):592-601. PubMed ID: 8555481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.